Evaluating the feasibility and preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): protocol for a feasibility cluster-randomised controlled trial

Trials. 2020 Mar 17;21(1):269. doi: 10.1186/s13063-020-4179-5.

Abstract

Background: Cognitive difficulties experienced by people with multiple sclerosis (MS) impact their quality of life and daily functioning, from childcare and work, to social and self-care activities. Despite the high prevalence of cognitive difficulties seen in MS, there is a lack of developed programmes that target cognition, while also supporting patients by helping them to function well in everyday life. The Cognitive Occupation-Based programme for people with MS (COB-MS) was developed as a holistic, individualised cognitive rehabilitation intervention. It addresses the wide-ranging symptoms and functional difficulties that present in MS, including the ability to maintain employment, social activities, home management and self-care. The aim of the current research is to evaluate the feasibility and preliminary efficacy of COB-MS for people with MS. The focus is on feasibility outcomes as well as functioning associated with cognitive difficulty and secondary outcomes related to cognition, fatigue and quality of life.

Methods: One hundred and twenty people with MS will be assigned to participate in either the COB-MS programme or a treatment as usual, wait-list control group as part of this single-blind, cluster-randomised controlled feasibility and preliminary efficacy trial of the COB-MS programme. The COB-MS group will participate in an eight-session occupational-based cognitive rehabilitation programme over 9 weeks. The primary outcome measure is the goal attainment scaling at 12 weeks. Participants will be assessed pre-intervention, post-intervention and at 12 weeks post-intervention and 6 months post-intervention. Qualitative evaluations of participants' perspectives will also be examined as part of the feasibility study.

Discussion: Results will provide recommendations for a future definitive trial of COB-MS, with respect to both feasibility and preliminary, clinical efficacy. In the event that results indicate efficacy, study findings will suggest that COB-MS requires consideration as a means of enhancing cognitive and daily functioning in people living with MS.

Trial registration: ISRCTN: ISRCTN11462710. Registered on 9 September 2019.

Keywords: Cognitive occupation-based programme; Cognitive rehabilitation; Feasibility; Multiple sclerosis; Occupational therapy; Protocol.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Activities of Daily Living
  • Cognition*
  • Cognitive Behavioral Therapy / economics
  • Cognitive Behavioral Therapy / methods*
  • Cost-Benefit Analysis
  • Feasibility Studies
  • Humans
  • Multiple Sclerosis / economics
  • Multiple Sclerosis / psychology
  • Multiple Sclerosis / rehabilitation*
  • Occupational Therapy / economics
  • Occupational Therapy / methods*
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Self Care
  • Single-Blind Method
  • Treatment Outcome